JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD.
Defendant: ASCEND LABORATORIES, LLC
Counter Defendant: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Counter Claimant: ALKEM LABORATORIES LTD.
Case Number: 1:2023cv02939
Filed: May 30, 2023
Court: US District Court for the District of New Jersey
Presiding Judge: Sharon A King
Referring Judge: Karen M Williams
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 28 U.S.C. § 1338 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on July 26, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 26, 2023 Set Deadlines as to #19 MOTION for Leave to Appear Pro Hac Vice of Samuel J. Ruggio, #18 MOTION for Leave to Appear Pro Hac Vice of Michael S. Weinstein. Motion set for 8/21/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (amv)
July 25, 2023 Filing 19 MOTION for Leave to Appear Pro Hac Vice of Samuel J. Ruggio by ALKEM LABORATORIES LTD.. (Attachments: #1 Certification of Samuel J. Ruggio, #2 Text of Proposed Order)(CAPUZZI, KEVIN)
July 25, 2023 Filing 18 MOTION for Leave to Appear Pro Hac Vice of Michael S. Weinstein by ALKEM LABORATORIES LTD.. (Attachments: #1 Certification of Michael S. Weinstein, #2 Text of Proposed Order)(CAPUZZI, KEVIN)
July 25, 2023 Opinion or Order Filing 17 TEXT ORDER: The Court having received the July 21, 2023 letter submitted by Keith J. Miller, Esquire [ECF No. 15], counsel for Plaintiff; it is hereby ORDERED that the initial conference scheduled for August 15, 2023 is RESCHEDULED to September 27, 2023 at 11:30 a.m. Counsel shall utilize the following dial-in instructions for the conference: 1-888-278-0296, Access Code 2961061#. So Ordered by Magistrate Judge Sharon A. King on 7/25/23. (mb, )
July 24, 2023 Opinion or Order Filing 16 TEXT ORDER: The initial scheduling conference on August 15, 2023 at 11:30 am shall be held VIA TELEPHONE. Counsel shall utilize the following dial-in instructions for the conference 1-888-278-0296 Access code 2961061#. Additionally, the joint discovery plan shall be filed on the docket. So Ordered by Magistrate Judge Sharon A. King on 7/24/23. (mb, )
July 21, 2023 Filing 15 Letter from Keith J. Miller, Esq. to Hon. Sharon A. King, U.S.M.J. Requesting Adjournment of Initial Scheduling Conference. (MILLER, KEITH)
July 20, 2023 Opinion or Order Filing 14 AMENDED Order Initial Conference set for 8/15/2023 at 11:30 AM in Teleconference before Magistrate Judge Sharon A. King. Signed by Magistrate Judge Sharon A. King on 7/20/2023. (amv)
July 20, 2023 Opinion or Order Filing 13 Order Initial Conference set for 8/15/2023 at 11:30 AM in Teleconference before Magistrate Judge Sharon A. King. Signed by Magistrate Judge Matthew J. Skahill on 7/20/2023. (amv)
July 20, 2023 Filing 12 Corporate Disclosure Statement by ALKEM LABORATORIES LTD.. (CAPUZZI, KEVIN)
July 20, 2023 Filing 11 ANSWER to Complaint , COUNTERCLAIM against JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC. by ALKEM LABORATORIES LTD..(CAPUZZI, KEVIN)
July 20, 2023 Filing 10 NOTICE of Appearance by KEVIN M. CAPUZZI on behalf of ALKEM LABORATORIES LTD. (CAPUZZI, KEVIN)
July 7, 2023 Set Deadlines as to #9 MOTION for Leave to Appear Pro Hac Vice on Consent. Motion set for 8/7/2023 before Magistrate Judge Sharon A. King. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (amv)
July 6, 2023 Filing 9 MOTION for Leave to Appear Pro Hac Vice on Consent by JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC.. (Attachments: #1 Declaration of Andrew Cohen, #2 Declaration of Aron Fischer, #3 Declaration of Barbara Mullin, #4 Declaration of Keith J. Miller, #5 Declaration of Jay Cho, #6 Declaration of Lachlan Campbell-Verduyn, #7 Declaration of Peter Vogel, #8 Declaration of Shelli Gimelstein, #9 Text of Proposed Order)(MILLER, KEITH)
June 16, 2023 Opinion or Order Filing 8 STIPULATION AND ORDER Dismissing Defendant ASCEND LABORATORIES, LLC. without Prejudice; Amending the case caption to remove Ascend; Extending the deadline for Alkem to file its answer to July 20, 2023. Signed by Judge Karen M. Williams on 6/16/2023. (amv)
June 15, 2023 Filing 7 Letter from Michael J. Gesualdo, Esq. to Hon. Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: #1 Text of Proposed Order)(GESUALDO, MICHAEL)
June 8, 2023 Filing 6 SUMMONS Returned Executed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. ASCEND LABORATORIES, LLC served on 6/7/2023, answer due 6/28/2023. (MILLER, KEITH)
June 8, 2023 Filing 5 SUMMONS Returned Executed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. ALKEM LABORATORIES LTD. served on 6/7/2023, answer due 6/28/2023. (MILLER, KEITH)
June 1, 2023 Filing 4 SUMMONS ISSUED as to ALKEM LABORATORIES LTD., ASCEND LABORATORIES, LLC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, )
June 1, 2023 Filing 3 AO120 Patent/Trademark Form filed. (ssp, )
June 1, 2023 Notice of Judicial Preferences. #Click here for the Judge's Individual Procedure Requirements. (ssp, )
May 31, 2023 Filing 2 Corporate Disclosure Statement by JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH)
May 30, 2023 Judge Karen M. Williams and Magistrate Judge Sharon A. King added. Judge Evelyn Padin no longer assigned to case. (dmw)
May 30, 2023 Filing 1 COMPLAINT against ALKEM LABORATORIES LTD., ASCEND LABORATORIES, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14351689), filed by JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(MILLER, KEITH)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System

Search for this case: JANSSEN PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: JANSSEN PHARMACEUTICALS, INC.
Represented By: KEITH J. MILLER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: JANSSEN PHARMACEUTICA NV
Represented By: KEITH J. MILLER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: ALKEM LABORATORIES LTD.
Represented By: KEVIN M. CAPUZZI
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: ASCEND LABORATORIES, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?